Prosecution Insights
Last updated: October 04, 2026

Mevion Medical Systems Inc.

Technology area: Semiconductors, Circuits & Optics

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Mevion Medical Systems Inc. is managing 3 pending office actions in the Semiconductors, Circuits & Optics technology area. These actions are distributed among 3 distinct examiners and 2 distinct art units. This means each pending matter is being reviewed by a different individual. The use of 2 distinct art units shows that the company's semiconductor and optics innovations are being evaluated across two different specialized groups.

Bernard Rojas is the busiest examiner for the portfolio, overseeing 1 pending office action. With 3 pending office actions in total, the prosecution effort is spread across multiple examiners. This decentralized structure means that the company is receiving feedback from 3 distinct examiners. This variety of examiner perspectives can lead to different prosecution experiences across the portfolio, as each of the 3 distinct examiners may have unique approaches to the examination process. Practitioners should be prepared to manage these matters across the 2 distinct art units involved in the current prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
1
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
Multi-statute (no §101)2 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
67% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROJAS, BERNARD 1 83.0% +7.8%
CHANG, HANWAY 1 86.1% +7.7%
SMITH, DAVID E 1 85.2% +7.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18580478 TOROIDAL GANTRY FOR A PARTICLE THERAPY SYSTEM SMITH, DAVID E 6d

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19100037 BENDING MAGNET ROJAS, BERNARD —
18726204 GANTRY CONFIGURED FOR TRANSLATIONAL MOVEMENT CHANG, HANWAY —

Top Art Units

Art UnitApps
2837 1
2881 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19100037 BENDING MAGNET ROJAS, BERNARD 2837 §102§103§112 Non-Final OA — Pending Jan 30, 2025
18726204 GANTRY CONFIGURED FOR TRANSLATIONAL MOVEMENT CHANG, HANWAY — §102§103§112 Non-Final OA — Pending Jul 02, 2024
18580478 TOROIDAL GANTRY FOR A PARTICLE THERAPY SYSTEM SMITH, DAVID E 2881 §103 Final Rejection 6d Pending Jan 18, 2024

Managing Mevion Medical Systems Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month